Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Strategy

- PMLiVE

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

- PMLiVE

Embracing the new paradigm in pharma market access

Pharma needs to change its image from being drug producers to healthcare provider partners

- PMLiVE

The journey to market access 5.0

Few in pharma are unaware of the importance of delivering demonstrable value in collaboration with payers. But are we serious about patient outcomes?

- PMLiVE

Merck KGaA acquires cancer drug from Symphogen

Will pay up to €495m for investigational metastatic colorectal cancer treatment

- PMLiVE

Market access webinar series begins with UK healthcare changes

Experts convene for first Sudler & Hennessey and Kantar Health online event

Roche - Basel

Roche says pipeline will balance cancer drug patent losses

Has 11 new molecular entities in late-stage portfolio and 11 line extensions

INC Research promotes Susan Akers-Smith to senior oncology role

She takes up the position of VP of early phase oncology development

Astellas wins US approval for prostate cancer drug Xtandi

Pharma company and its partner Medivation gain FDA licence for type of late-stage prostate cancer

- PMLiVE

Astellas Pharma Europe appoint new senior director, market access

Dr Susan Wood was previously senior brand director of the company’s pain management franchise 

- PMLiVE

Interview: Deepak Khanna, ABPI

Collaboration, communication and an appropriate drug pricing scheme are key says ABPI president

- PMLiVE

Interview: Dan Mathews on pharma marketing trends and the PMEA programme

The chair of judges for PMEA 2012 examines the current and future challenges for the sector

Interview: Dan Mathews on pharma marketing trends and the PMEA programme

The chair of judges for PMEA 2012 examines the current and future challenges for the sector

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links